The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%

3
health-fitness

Summary

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological research

Press Release

Amazon Music Disney Promo

Roots Analysis has announced the addition of “RNAi Therapeutics Market (2nd Edition), 2019-2030” report to its list of offerings.

 

Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have inspired research groups across the world, to focus their efforts on the development of RNAi therapeutics.

 

To order this 350+ page report, which features 130+ figures and 190+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market-2nd-edition-2019-2030/278.html

Key Market Insights

 

Over 170 RNAi therapeutics are currently under development

Nearly 30% of pipeline drugs are in the clinical phase, while the rest are either in the preclinical / discovery stage. The majority of pipeline drug candidates are delivered using siRNA conjugated delivery technology platform to mitigate targeted delivery to organ / cell.

 

More than 70% of ongoing clinical trials are being conducted in North America and Europe

In total, we came across over 100 clinical trials that have been / are being conducted across the globe. It is worth noting that around 40% of these trials were observed to be phase II studies. Further, 75% of the active clinical trials being conducted in this domain are evaluating siRNAs.

 

To request a sample copy / brochure of this report, please visit this – https://www.rootsanalysis.com/reports/278/request-sample.html

                                                                                     

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry.

Contact Details

Ben Johnson

+1 (415) 800 3415

[email protected]

 

Roots Analysis

Web: https://www.rootsanalysis.com/